Intellia Therapeutics, Inc.

NTLA

Log in to follow and get free email alerts when insiders file.

Sector

In Vitro And In Vivo Diagnostic Substances

Industry

Drugs

Website

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    9.1%90.9%

    $4.44M

    avg. $4.44M

    $44.45M

    avg. $44.45M

    Buy/Sell Ratio

    0.1


    Transactions

    51

    Filers

    6

    3 Month

    4.1%95.9%

    $5.48M

    avg. $5.48M

    $127.95M

    avg. $42.65M

    Buy/Sell Ratio

    0.043


    Transactions

    92

    Filers

    17

    12 Month

    7.2%92.8%

    $16.12M

    avg. $16.12M

    $207.15M

    avg. $17.26M

    Buy/Sell Ratio

    0.078


    Transactions

    181

    Filers

    44

    24 Month

    7.3%92.7%

    $16.36M

    avg. $16.36M

    $207.63M

    avg. $8.65M

    Buy/Sell Ratio

    0.079


    Transactions

    189

    Filers

    59

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1581992Goddard GlennEVP, Chief Financial Officer2021-09-092020-03-04
    1563584LEONARD JOHN M.President and CEO2021-09-012020-03-04
    1777421Sepp-Lorenzino LauraEVP, Chief Scientific Officer2021-09-012020-03-04
    1810882Lebwohl DavidEVP, Chief Medical Officer2021-09-012020-05-05
    1030575FORMELA JEAN FRANCOIS2021-06-292020-06-19
    1545794Verwiel Frank2021-06-252020-06-19
    1756929GOODMAN JESSE2021-06-252020-06-19
    1181174DORSA CAROLINE2021-06-252020-06-19
    1400973Crowley John F2021-06-252020-10-05
    1339358Cohen Fred E2021-06-252021-06-25
    1773532Keresty Georgia2021-06-252021-06-25
    1738456SCHIERMEIER ANDREWEVP, Chief Operating Officer2021-03-052020-03-04
    1671870Rivera Jose EEVP, General Counsel2021-03-052020-03-04
    1260573KARSEN PERRY A2020-12-182020-06-19